01/10/2025 7:30 AM | MetaVia Inc. (Filer) MetaVia Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2024 7:30 AM | MetaVia Inc. (Filer) MetaVia Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/02/2024 4:31 PM | Kim Hyung Heon (Reporting) MetaVia Inc. (Issuer) MetaVia Inc. (Issuer) MetaVia (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/29/2024 8:10 AM | MetaVia Inc. (Filer) MetaVia Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/18/2024 7:35 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/07/2024 6:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2024 7:07 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2024 3:20 PM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2024 3:10 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MTVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MetaVia and its competitors with MarketBeat's FREE daily newsletter.
|
08/14/2024 7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 7:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form PRE 14A | |
07/30/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2024 11:15 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form EFFECT | |
07/24/2024 4:11 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 424B3 | |
07/18/2024 7:21 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
07/16/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2024 10:11 AM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer)
| Form 4/A | |
06/26/2024 8:15 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 3:15 PM | DONG-A ST CO., LTD (Filed by) NeuroBo Pharmaceuticals, Inc. (Subject) NeuroBo Pharmaceuticals, Inc. (Subject) MetaVia (Subject)
| Form SC 13D/A | |
06/25/2024 3:16 PM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 7:21 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 424B5 | |
06/25/2024 7:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/24/2024 5:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 6:24 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer) Tursi James Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:24 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer) STRICKLAND D GORDON (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:25 PM | Glickman Mark A (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:25 PM | KOVEN ANDREW I (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:26 PM | GROVES JASON L (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:26 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer) Salsbury Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 8:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 7:05 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2024 7:41 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form DEF 14A | |
04/30/2024 7:42 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form ARS | |
04/30/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2024 11:15 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form EFFECT | |
04/17/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:30 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
How This Indicator Nailed Nvidia’s Last Two Rallies Perfectly (Ad) I’m not one to make super bold statements…
But today, I’m making an exception.
Because I’m 100% convinced this is the best indicator I’ve used for trading Nvidia…
Don’t believe me? Just take a look at the last two rallies:
This powerful indicator caught both moves almost perfectly. Don’t miss out—this could be the next big move. |
04/01/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2024 8:20 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals, Inc. (Issuer) MetaVia (Issuer) Woodworth Marshall H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 7:52 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals, Inc. (Filer) MetaVia (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |